Related Experiment Videos

The protective effect of propofol on erythrocytes during cardiopulmonary bypass

S Zhang1, S Yao

  • 1Department of Anesthesiology, Xiehe Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022.

Journal of Tongji Medical University = Tong Ji Yi Ke Da Xue Xue Bao
|August 29, 2001
PubMed

Insights

Propofol protects red blood cells from injury during cardiopulmonary bypass (CPB). Elevated intracellular calcium in erythrocytes during CPB correlates with cell damage, an effect mitigated by propofol.

Area of Science:

  • Cardiovascular Surgery
  • Anesthesiology
  • Hematology

Background:

  • Cardiopulmonary bypass (CPB) can lead to erythrocyte (red blood cell) injury.
  • Intracellular calcium overload is a potential mechanism for this injury.
  • Understanding protective strategies is crucial for pediatric cardiac surgery.

Purpose of the Study:

  • To investigate the link between erythrocyte intracellular calcium levels and cell injury during CPB.
  • To evaluate the protective effects of propofol on erythrocytes in children undergoing CPB.

Main Methods:

  • 40 children with congenital heart disease undergoing CPB were studied.
  • Patients were randomized into control (isoflurane) and propofol anesthesia groups.
  • Erythrocyte intracellular calcium, enzyme activities (Ca(2+)-Mg(2+)-ATPase, Na(+)-K(+)-ATPase), erythrocyte filtration index, mean corpuscular volume, and plasma free hemoglobin were measured.

Main Results:

  • In the control group, erythrocyte intracellular calcium, filtration index, mean corpuscular volume, and plasma free hemoglobin increased, while enzyme activities decreased.
  • A linear correlation was observed between increased erythrocyte intracellular calcium and markers of cell injury.
  • The propofol group showed significant improvements in all measured parameters compared to the control group (P < 0.05).

Conclusions:

  • Erythrocyte injury during CPB is associated with elevated intracellular calcium levels.
  • Propofol demonstrates a protective effect against erythrocyte injury in this context.
  • These findings suggest propofol as a potential therapeutic agent to mitigate red blood cell damage during CPB.

Related Concept Videos